Cytisinicline could offer adult cigarette smokers a potential new treatment option

AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Ankylosing Spondylitis (Bekhterev’s Disease).

No­vo Nordisk is strik­ing back against il­le­gal semaglu­tide com­pounders, fil­ing an ini­tial five law­suits and prepar­ing more in the com­ing days and weeks. The first

The FDA ap­proved Re­gen­eron’s poze­limab, the first treat­ment for a rare, hered­i­tary im­mune dis­ease that af­fects few­er than 100 peo­ple world­wide. The mon­o­clon­al an­ti­body, to